| Dr Jayson Johnson, MD | |
|
901 N Curtis Rd Ste 304, Boise, ID 83706-1341 | |
| (208) 342-4263 | |
| (208) 375-0597 |
| Full Name | Dr Jayson Johnson |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 9 Years |
| Location | 901 N Curtis Rd Ste 304, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841673118 | NPI | - | NPPES |
| 2015021994 | Other | MO | MISSOURI DIVISION OF PROFESSIONAL REGISTRATION |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2015021994 (Missouri) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | M15661 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Idaho Hand Center, Pa | 9830250091 | 7 |
News Archive
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
An analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients with mild or moderate depression, but appear to provide substantial benefit for patients with very severe depression, according to an article in the January 6 issue of JAMA.
Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.
Case Western Reserve researchers have discovered landmarks within pluripotent stem cells that guide how they develop to serve different purposes within the body.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
› Verified 4 days ago
| Entity Name | Idaho Hand Center, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457530131 PECOS PAC ID: 9830250091 Enrollment ID: O20081205000446 |
News Archive
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
An analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients with mild or moderate depression, but appear to provide substantial benefit for patients with very severe depression, according to an article in the January 6 issue of JAMA.
Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.
Case Western Reserve researchers have discovered landmarks within pluripotent stem cells that guide how they develop to serve different purposes within the body.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jayson Johnson, MD 901 N Curtis Rd Ste 304, Boise, ID 83706-1341 Ph: (208) 577-5342 | Dr Jayson Johnson, MD 901 N Curtis Rd Ste 304, Boise, ID 83706-1341 Ph: (208) 342-4263 |
News Archive
Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).
An analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients with mild or moderate depression, but appear to provide substantial benefit for patients with very severe depression, according to an article in the January 6 issue of JAMA.
Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.
Case Western Reserve researchers have discovered landmarks within pluripotent stem cells that guide how they develop to serve different purposes within the body.
ZIOPHARM Oncology, Inc., announced today that the first patient has been dosed in a Phase I, single arm, dose escalation study at the Indiana University Cancer Center of intravenous (IV) palifosfamide (ZIO-201) in combination with etoposide (VP-16) and cisplatin/carboplatin (platinum) in the treatment of small cell lung cancer (SCLC) and other cancers.
› Verified 4 days ago
Tracye Jean-marie Lawyer, MD, PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8950 W Emerald St Ste 168, Boise, ID 83704 Phone: 208-321-1209 Fax: 208-321-1211 | |
Dustin I Judd, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Robbins Rd, Suite 100, Boise, ID 83702 Phone: 208-383-0201 | |
Dr. Michael Glover, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 500 W Fort St, Mail Code #112, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1082 | |
Jeffrey D Smith, PA C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7979 W Rifleman St, Boise, ID 83704 Phone: 208-989-0598 | |
Howard A King, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 N Robbins Rd, Ste 100, Boise, ID 83702 Phone: 208-383-0201 Fax: 208-489-4300 | |
Dr. Jeffrey Glenn Hessing, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8854 W Emerald St, Suite 140, Boise, ID 83704 Phone: 208-327-4790 Fax: 208-367-4888 | |
Dr. Kirk J Lewis, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1188 University Dr, Boise, ID 83706 Phone: 208-336-8250 Fax: 208-345-9514 |